GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SRBZF) » Definitions » Cyclically Adjusted Revenue per Share

Stratec SE (Stratec SE) Cyclically Adjusted Revenue per Share : $37.93 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Stratec SE's adjusted revenue per share for the three months ended in Mar. 2024 was $4.548. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $37.93 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Stratec SE's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Stratec SE was 11.70% per year. The lowest was 6.40% per year. And the median was 10.30% per year.

As of today (2024-06-06), Stratec SE's current stock price is $72.9551. Stratec SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $37.93. Stratec SE's Cyclically Adjusted PS Ratio of today is 1.92.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stratec SE was 9.22. The lowest was 1.80. And the median was 4.96.


Stratec SE Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Stratec SE's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Cyclically Adjusted Revenue per Share Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.63 8.80 8.87 17.21 33.06

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.08 23.16 33.78 33.06 37.93

Competitive Comparison of Stratec SE's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Stratec SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Stratec SE's Cyclically Adjusted PS Ratio falls into.



Stratec SE Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stratec SE's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.548/125.0381*125.0381
=4.548

Current CPI (Mar. 2024) = 125.0381.

Stratec SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.989 99.543 5.011
201409 3.942 99.823 4.938
201412 4.107 99.543 5.159
201503 3.150 99.717 3.950
201506 3.347 100.417 4.168
201509 3.506 100.417 4.366
201512 3.615 99.717 4.533
201603 2.914 100.017 3.643
201606 4.407 100.717 5.471
201609 4.538 101.017 5.617
201612 5.178 101.217 6.397
201703 4.438 101.417 5.472
201706 4.796 102.117 5.873
201709 4.973 102.717 6.054
201712 5.721 102.617 6.971
201803 4.067 102.917 4.941
201806 4.783 104.017 5.750
201809 4.430 104.718 5.290
201812 5.036 104.217 6.042
201903 4.377 104.217 5.251
201906 5.817 105.718 6.880
201909 4.543 106.018 5.358
201912 5.129 105.818 6.061
202003 5.173 105.718 6.118
202006 5.836 106.618 6.844
202009 5.785 105.818 6.836
202012 7.081 105.518 8.391
202103 7.040 107.518 8.187
202106 8.292 108.486 9.557
202109 6.724 109.435 7.683
202112 5.743 110.384 6.505
202203 6.817 113.968 7.479
202206 5.366 115.760 5.796
202209 5.735 118.818 6.035
202212 5.830 119.345 6.108
202303 5.318 122.402 5.433
202306 5.750 123.140 5.839
202309 5.502 124.195 5.539
202312 6.659 123.773 6.727
202403 4.548 125.038 4.548

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Stratec SE  (OTCPK:SRBZF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Stratec SE's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=72.9551/37.93
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stratec SE was 9.22. The lowest was 1.80. And the median was 4.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Stratec SE Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Stratec SE's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Industry
Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus